Images List Premium Download Classic

Autologous

Autologous-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Method for producing autologous tolerogenic dendritic cells (toldcs) with specific antigens and their use in ...
Pontificia Universidad Catolica De Chile
July 13, 2017 - N°20170196950

The invention relates to a method for producing tolerogenic dendritic cells (toldcs) with specific antigens, comprising the steps of: (a) culturing precursors of dendritic cells in an animal-serum-free medium, using cytokines, il-4 and gm-csf, in order to differentiate same in dendritic cells; (b) producing apoptotic cells; (c) culturing the dendritic cells obtained in step (b) in the presence of compounds ...
Gamma delta t cells and uses thereof
Tc Biopharm Ltd
July 13, 2017 - N°20170196910

A method of preparing and using gamma delta t cells in the allogeneic or autologous treatment of subjects suffering from virus infection, fungal infection, protozoal infection and cancer.
Cobalt porphyrins for the treatment of blood-related disorders
Uniwersytet Jagiellonski
July 13, 2017 - N°20170196882

The use of cobalt porphyrins for the manufacture of an agent for mobilizing bone marrow cells to peripheral blood, preferably used to treat congenital neutropenia, for the treatment and prevention of neutropenia caused by chemotherapy, radiotherapy and pharmacologically-induced neutropenia, for the treatment of acute myeloid leukemia, acute lymphocytic leukemia, myelodysplastic syndromes, and to increase the amount of circulating hematopoietic stem ...
Autologous Patent Pack
Download + patent application PDFs
Autologous Patent Applications
Download + Autologous-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Autologous-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Tissue transplant compositions and methods for use
Parcell Laboratories Llc
June 08, 2017 - N°20170157291

Provided are transplants and methods for augmenting formation and restoration of organ and tissue, for example, bone formation, by administering autologous or allogeneic human embryonic-like adult stem cells (ela cells). Also provided is a method for augmenting formation of tissues and organs by administering a transplant having ela stem cells or combination of ela stem cells.
Cellular compositions used to restore stem cell or progenitor cell function and methods related thereto
Emory University
June 08, 2017 - N°20170157178

This disclosure relates to compounds, compositions and methods of epigenetically transforming cells. In certain embodiments, the disclosure relates to methods of generating epigenetically altered cells comprising mixing isolated cells with compositions disclosed herein under conditions such that epigenetically altered cells are formed. In certain embodiments, methods of treating or preventing vascular or diabetic diseases or conditions are contemplated. In certain ...
Inactivation of lymphocyte immunological checkpoints by gene editing
Batu Biologics, Inc.
June 01, 2017 - N°20170152506

Disclosed are methods, protocols, and compositions of matter useful for generation of lymphocytes with permanently inactivated immunological checkpoint genes, said genes comprising pd-1, ctla-4, lag-3, and tim-3. The generated lymphocytes may be autologous or allogeneic, and are useful in the treatment of neoplastic, viral or bacterial infections.
Autologous Patent Pack
Download + patent application PDFs
Autologous Patent Applications
Download + Autologous-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Autologous-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compositions, kits and methods for in vitro antigen presentation, assessing vaccine efficacy, and assessing immunotoxicity ...
Wilson Wolf Manufacturing Corporation
May 25, 2017 - N°20170146526

Nanoparticle-based compositions, assays, kits, methods and platforms for delivering an antigen (peptides, proteins) or a nucleic acid encoding an antigen to professional apcs (papcs) result in the generation of autologous apcs that present a natural peptide repertoire of the antigen for use in assessing the efficacy of a vaccine (e. G., a cytotoxic t lymphocyte (ctl) response to a particular ...
Apparatus and method for expanding skin
Wilson Wolf Manufacturing Corporation
May 25, 2017 - N°20170145371

An embodiment of the present invention provides an apparatus and method for expanding skin capable of expanding autologous skin to the maximum extent and performing a tissue culture of skin at the outside of the body. While an apparatus for expanding autologous skin of body's outside in general takes a form of expanding skin by applying a certain amount of ...
System for generating high concentration factors for low cell density suspensions
Flodesign Sonics, Inc.
May 18, 2017 - N°20170137802

Acoustophoretic devices and methods for concentrating targeted biological cells in a reduced volume using multi-dimensional acoustic standing waves are disclosed. The methods include flowing a mixture of a host fluid and the biological cells through an acoustophoretic device. The acoustophoretic devices include an inlet, an outlet, and a flow chamber having an ultrasonic transducer-reflector pair. Biological cells, such as t ...
Pluripotent autologous stem cells from oral mucosa and methods of use
Ramot At Tel-aviv University Ltd.
May 18, 2017 - N°20170137778

The present invention provides a new readily accessible source of adult somatic stem cells from the gastrointestinal tract in general and oral mucosa in particular, methods for isolating pluripotent stem cells from oral mucosa, cells derived therefrom and uses thereof.
Dna vector and transformed tumor cell vaccines
Morphogenesis, Inc.
May 18, 2017 - N°20170136109

Customized whole cell cancer vaccines can be produced from autologous (ex vivo or in situ) or allogeneic human or veterinary patient cell lines. Cells are transformed with s. Pyogenes dna that expresses an emm protein on the cell surface and cytosol. Treatment of cancer patients with an emm vector vaccine induces an immunologic response to the cancer by enhancing immunogenicity ...
Stem cell therapy in endometrial pathologies
Igenomix S.l.
May 11, 2017 - N°20170128492

The invention generally relates to the ability of autologous cd133+ bone marrow stem cells (bmdsc) to induce endometrial regeneration and treat endometrial pathologies such as asherman's syndrome and endometrial atrophy. Methods to induce endometrial regeneration are provided, which comprises administering an effective amount of autologous cd133+ bone marrow derived stem cells (bmdsc) into uterine arteries of a subject in need ...
Method for obtaining globally activated monocytes
Yale University
May 11, 2017 - N°20170128490

The present invention relates to methods for producing immuno-stimulatory autologous dendritic cells. The present invention further relates to the use of such cells for treating patients suffering from hyper-proliferative disease such as cancer.
Autologous Patent Pack
Download + patent application PDFs
Autologous Patent Applications
Download + Autologous-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Autologous-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Graft including osseous tissue and cartilage tissue for augmentation rhinoplasty, and method of performing augmentation ...
Ningbo Jenscare Biotechnology Co., Ltd.
April 27, 2017 - N°20170112615

A graft for augmentation rhinoplasty, the graft including bone tissue and cartilage tissue, and a method of performing augmentation rhinoplasty by using the graft are disclosed. According to the disclosure, autologous tissue for augmentation rhinoplasty can be obtained in a sufficient amount to so that a nose can be uplifted to a desired height. In addition, rhinoplasy can be easily ...
Fusion proteins of collagen-binding domain and parathyroid hormone
The Board Of Trustees Of The University Of Arkansas
April 13, 2017 - N°20170101457

Fusion proteins containing active agonist or antagonist fragments of parathyroid hormone (pth) and parathyroid hormone related peptide (pthrp) coupled to a collagen-binding domain are presented. The fusion proteins can be used to promote bone growth, to promote hair growth, to prevent cancer metastasis to bone, to promote immune reconstitution with a bone marrow stem cell transplant, to promote mobilization of ...
Vaccination with immuno-isolated cells producing an immunomodulator
Maxivax Sa
April 06, 2017 - N°20170095546

Provided herein are vaccine compositions containing at least one retrievable biocompatible macrocapsule containing immuno-isolated allogeneic cells that secrete an immunomodulator such as gm-csf (granulocyte-macrophage colony stimulating factor) and an antigenic component such as autologous tumor cells or infectious agents. Also provided are kits and pharmaceutical compositions containing the vaccine compositions as well as methods of use thereof for therapeutic or ...
Vaccination with immuno-isolated cells producing an immunomodulator
Maxivax Sa
March 30, 2017 - N°20170087234

Provided herein are vaccine compositions containing at least one retrievable biocompatible macrocapsule containing immuno-isolated allogeneic cells that secrete an immunomodulator such as gm-c sf (granulocyte-macrophage colony stimulating factor) and an antigenic component such as autologous tumor cells or infectious agents. Also provided are kits and pharmaceutical compositions containing the vaccine compositions as well as methods of use thereof for therapeutic ...
Plasma-enriched hydroxyapatite-based filler material and method of filling bone gaps with the same
Metrex Research, Llc
March 23, 2017 - N°20170080122

Plasma-enriched hydroxyapatite-based fillers and methods of filling bone gaps in oral surgery, orthopedic procedures, and cosmetic surgery are disclosed. The fillers contain a substance comprising an anticoagulant antidote, a substance comprising hydroxyapatite, and blood or plasma. The blood may be either autologous or allogeneic. The fillers have a dough-like consistency and can be manipulated easily by a surgeon.
Expanded utility of red-cell derived microparticles (rmp) for treatment of bleeding
University Of Miami
March 23, 2017 - N°20170080027

Red blood cell membrane derived microparticles (rmp) are safe, economical, effective hemostatic agents in the treatment of a wide range of bleeding conditions and can, therefore, be considered as universal hemostatic agents. Effective rmp are produced from red blood cells using a high-pressure extrusion membrane shear process. The rmp can be lyophilized after production and retain activity even when stored ...
Failsafe percutaneous wound barrier
University Of Miami
March 09, 2017 - N°20170065284

Provided are approaches to establish a failsafe barrier to internal bleeding from percutaneous wounds. As provided herein, a barrier is formed to protect a patient from failed wound closure devices or related complications due to a variety of contributing factors such as state of systemic anticoagulation, errors in surgical procedure, variability in patient anatomy, and the like. The methods described ...
Fgf-18 in graft transplantation and tissue engineering procedures
Merck Patent Gmbh
March 02, 2017 - N°20170056554

The present invention provides a new method related to regenerative medicine for the treatment of cartilage disorders, osteoarthritis and cartilage injury in particular. More particularly, it relates to an fgf-18 compound for use in tissue engineering and graft procedures, such as osteochondral or cartilage transplantation or autologous chondrocyte implantation (aci).
Loading